Kronos Bio
KRON
KRON was delisted on the 20th of June, 2025.
60 hedge funds and large institutions have $33.4M invested in Kronos Bio in 2023 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 12 increasing their positions, 18 reducing their positions, and 9 closing their positions.
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
5% less funds holding
Funds holding: 63 → 60 (-3)
6.03% less ownership
Funds ownership: 51.9% → 45.86% (-6%)
15% less capital invested
Capital invested by funds: $39.3M → $33.4M (-$5.9M)
22% less first-time investments, than exits
New positions opened: 7 | Existing positions closed: 9
33% less repeat investments, than reductions
Existing positions increased: 12 | Existing positions reduced: 18
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Cerity Partners
New York
|
+$455K |
| 2 |
Fidelity Investments
Boston,
Massachusetts
|
+$399K |
| 3 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
+$269K |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$50.9K |
| 5 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$50.3K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
NI
Nextech Invest
Zurich,
Switzerland
|
-$1.89M |
| 2 |
Mariner
Overland Park,
Kansas
|
-$1.19M |
| 3 |
ACP
Acuta Capital Partners
Redwood City,
California
|
-$934K |
| 4 |
AG
Artal Group
Luxembourg
|
-$775K |
| 5 |
BlackRock
New York
|
-$346K |
KRON Hedge Fund Activity: Q4 2023 in Review
60 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Kronos Bio (KRON) for Q4 2023, worth a combined $33.4M — down 15% from $39.3M a quarter earlier.
Sellers outnumbered buyers: 9 funds closed out of KRON and 7 opened new positions — a net loss of 2 holders — while 18 trimmed existing stakes and 12 added.
The largest buyer was Cerity Partners, opening a new position worth an estimated $455K. The largest seller was Nextech Invest, exiting entirely with an estimated $1.89M sold.
- 60 institutional investors held Kronos Bio (KRON) as of Q4 2023, down from 63 in Q3 2023.
- Funds reported $33.4M of Kronos Bio stock for Q4 2023, down 15% quarter-over-quarter.
- 7 funds opened new Kronos Bio positions in Q4 2023 and 9 closed out, a net change of -2 holders.
- The largest Kronos Bio buyer in Q4 2023 was Cerity Partners, an estimated $455K added.
- The largest Kronos Bio seller in Q4 2023 was Nextech Invest, an estimated $1.89M sold.
Based on aggregated 13F filings for Q4 2023.